Atlas Trials

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

Clinical trial NCT01912196 · COMPLETED

Trial details

NCT number
NCT01912196
Sponsor
MSI Methylation Sciences, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder (MDD)
Start date
2013-10-01
Primary completion
2015-09-01
Enrollment
376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.